Development of a Prognostic Scoring System for Hepatocellular Carcinoma Patients With Main Portal Vein Tumor Thrombus Undergoing Conventional Transarterial Chemoembolization: An Analysis of 173 Patients

BACKGROUND: Patients with hepatocellular carcinoma (HCC) with main portal vein tumor thrombus (mPVTT) have poor prognosis. Promising systemic therapies, such as target therapies, have limited benefits. The purpose of this study is to retrospectively evaluate the benefits of conventional TACE (c-TACE...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jing-huan, Yin, Xin, Fan, Wen-shuai, Zhang, Lan, Chen, Rong-xin, Chen, Yi, Li, Li-xin, Ge, Ning-ling, Gan, Yu-hong, Wang, Yan-hong, Ren, Zheng-gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427599/
https://www.ncbi.nlm.nih.gov/pubmed/34513667
http://dx.doi.org/10.3389/fonc.2021.671171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427599/
https://www.ncbi.nlm.nih.gov/pubmed/34513667
http://dx.doi.org/10.3389/fonc.2021.671171

Ejemplares similares